RecruitingNot ApplicableNCT07779967

Alcohol, Breast Cancer, and Metabolism

Localized Mammary Alcohol Metabolism as a Mechanism Linking Low-Level Alcohol Intake to Breast Cancer Risk


Sponsor

University of Illinois at Urbana-Champaign

Enrollment

50 participants

Start Date

Sep 3, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Alcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear. This study will examine whether breast tissue may locally metabolize alcohol by measuring alcohol-related compounds in paired blood and breast milk samples from lactating women. The findings may help clarify alcohol-related biological pathways relevant to breast cancer risk and improve risk communication.


Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Breast-pumping time and Low-alcohol level exposure for people with alcohol drinking, breastfeeding, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 21 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLow-alcohol level exposure

Participants will consume a protocol-specified low-level alcohol exposure under study conditions. The assigned dose and biospecimen collection procedures will vary by study group.

OTHERBreast-pumping time

Breast pumping before or after drinking \~ 1 standard drink or placebo drink


Locations(1)

Bevier Hall; University of Illinois at Urbana Champaign

Urbana, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07779967


Related Trials